Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aggressive Therapy
5%
Biomarqueurs
13%
Brain Damage
7%
Cardiac Arrest
54%
Cardiovascular Disease
41%
Cardiovascular Pathophysiology
13%
Cardiovascular System
27%
Challenging Tasks
5%
Circular RNA
27%
Circulating Circular RNA
13%
Clinical Outcomes
27%
Eukaryotic Cells
13%
Four-core
13%
Healthcare
5%
Heterogeneous Disorders
6%
High Risk
5%
Hospital Discharge
5%
Internal Modification
13%
M6A Modification
13%
M6A RNA Methylation
13%
Management Experiment
13%
Mechanism of Action
13%
Messenger RNA (mRNA)
13%
N6-methyladenosine
27%
Neurological Outcome
13%
Neurological Symptoms
5%
Neuroprognostication
27%
Non-coding RNA (ncRNA)
81%
Novel Biomarkers
10%
Outcome Prediction
16%
Parkinson's Disease Biomarkers
6%
Patient Identification
5%
Physical Symptoms
5%
Poor Recovery
5%
Postnatal Development
13%
Potential Therapeutics
13%
Precision Medicine
5%
Prenatal Development
13%
Resuscitation
5%
RNA Modification
27%
RNA Molecules
27%
Sex Differences
27%
Socioeconomic Burden
5%
Specificity Protein 1
13%
Sudden Cardiac Death
5%
Survival Rate
5%
Swedish Research Council
9%
Targeted Temperature Management
13%
Therapeutic Role
13%
Transcriptome
27%
Biochemistry, Genetics and Molecular Biology
Biomarker Research
6%
Cardiac Arrest
81%
Circular RNA
61%
Clinical Research
27%
Clinical Study
5%
Experimental Model
10%
Genetics
12%
Long Non-Coding RNA
6%
Mediator
5%
Medical Biology
6%
Messenger RNA
13%
MicroRNA
6%
Mortality Rate
5%
N6-Methyladenosine
27%
Non-Coding RNA
100%
Postnatal Development
13%
Prenatal Development
13%
Prevalence
5%
Prognostic Biomarker
27%
Regulatory Network
6%
RNA
40%
RNA Methylation
13%
RNA Modification
27%
Sex Differences
27%
Transcription
5%
Transcriptome
31%